Onconova Therapeutics Inc. (ONTX) Fundamentals

Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.
SHARE INFORMATION
Market Cap$ 28,000,054
Shares Outstanding20,895,563
Float20,798,541
Percent Float99.54%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 226,000
Latest Fiscal EPS$ -0.97
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions61
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months307,909
Institutional Holdings Percent13.5%
Institutional Sold Previous 3 Months408,333
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months66,750
Insider Holdings Percent3.7
Insider Sold Previous 3 Months-
Insider Shares Owned769,138
TRADING INFO
52 Week High$ 6.77
52 Week Low$ 1.00
52 Week High Change$ -74.13
21 Day Moving Average$ 1.2634
21 Day Extended Moving Average$ 1.2872
50 Day Moving Average$ 1.2892
50 Day Extended Moving Average$ 1.2987
200 Day Moving Average$ 1.89
200 Day Extended Moving Average$ 2.3154
10 Day Average Volume248,464
20 Day Average Volume173,226
30 Day Average Volume134,483
50 Day Average Volume130,709
Alpha-0.043143
Beta1.5180
Standard Deviation0.355122
R20.045710
7 Day Price Change$ -0.11
7 Day Percent Change-7.59%
21 Day Price Change$ 0.11
21 Day Percent Change8.94%
30 Day Price Change$ -0.03
30 Day Percent Change-2.19%
Month to Date Price Change$ 0.1355
Month to Date Percent Change11.25%
Quarter to Date Price Change$ 0.02
Quarter to Date Percent Change1.52%
180 Day Price Change$ -0.29
180 Day Percent Change-17.79%
200 Day Price Change$ -0.55
200 Day Percent Change-29.1%
Year to Date Price Change$ -1.21
Year to Date Percent Change-47.45%

Onconova Therapeutics Inc. (ONTX) Key Ratios

PROFITABILITY
EBIT Margin-7,314.2%
EBITDA Margin-7,308.0%
Pre-Tax Profit Margin-4,665.3%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 169,000
Revenue Per Share$ 0.0081
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio8.60
Leverage Ratio1.20
Quick Ratio8.50
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.60
Enterprise Value$ -23,235,007
Price to Sales165.6808
Price to Free Cash-2.20
PE High Last 5 Years-0.60
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years-1.20
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.90
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-31.06
Return on Equity-39.20
Return on Capital-39.20

Onconova Therapeutics Inc. (ONTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOSteven M. Fruchtman
Emplyoees15
Last AuditUQ
CIK0001130598
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address12 Penns Trail
Newtown, PA 18940
Websitehttps://www.onconova.com
Facsimile+1 267 759-3681
Telephone+1 267 759-3680
Emailir@onconova.us


Your Recent History
NASDAQ
ONTX
Onconova T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.